Tristel PLC
LSE:TSTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tristel PLC
Cash from Financing Activities
Tristel PLC
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tristel PLC
LSE:TSTL
|
Cash from Financing Activities
-£7.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-18%
|
|
|
Abingdon Health PLC
LSE:ABDX
|
Cash from Financing Activities
£5.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
ConvaTec Group PLC
LSE:CTEC
|
Cash from Financing Activities
-$258m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Inspecs Group PLC
LSE:SPEC
|
Cash from Financing Activities
-£426k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Cash from Financing Activities
-£19m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-32%
|
|
|
Rua Life Sciences PLC
LSE:RUA
|
Cash from Financing Activities
-£459k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Tristel PLC
Glance View
Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire and currently employs 189 full-time employees. The company went IPO on 2005-06-01. The Company’s technology is a chlorine dioxide formulation used by hospitals for the high-level disinfection of medical devices and the sporicidal disinfection of environmental surfaces. The Company’s segments include Hospital medical device decontamination and Hospital environmental surface disinfection. The firm manufactures and sells medical device decontamination products that are used primarily for infection control in hospitals. The firm also manufactures and sells hospital environmental surface disinfection products. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, phlebotomy, surfaces, ultrasound, urology, and women's health. The Crystel brand offers pharmaceutical, cosmetic and toiletry (PCT), cleanroom disinfectants and laboratory disinfectants. The company markets its products under the Tristel, Anistel, and Crystel brands.
See Also
What is Tristel PLC's Cash from Financing Activities?
Cash from Financing Activities
-7.7m
GBP
Based on the financial report for Dec 31, 2025, Tristel PLC's Cash from Financing Activities amounts to -7.7m GBP.
What is Tristel PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-18%
Over the last year, the Cash from Financing Activities growth was -13%. The average annual Cash from Financing Activities growth rates for Tristel PLC have been -11% over the past three years , -23% over the past five years , and -18% over the past ten years .
